电压门控钙通道与GABA能信号在NTSR2镇痛中的双重作用
该研究在围术期与慢性疼痛的啮齿类模型中探讨NTSR2激动剂NT79的镇痛效应及机制。鞘内注射NT79产生剂量依赖性镇痛,该效应依赖NTSR2并被其敲低废除。机制涉及抑制DRG神经元高电压激活钙电流及增强脊髓GABA释放、抑制CGRP释放的双位点调控。
要点
- NTSR2激动剂NT79在多种疼痛模型、种属和性别中产生稳健的剂量依赖性镇痛。
- NT79镇痛依赖NTSR2,敲低NTSR2可废除其效应。
- 机制为抑制DRG钙电流和增强脊髓GABA能信号的双位点调控。
核心结论
- NTSR2激活通过抑制外周电压门控钙通道和增强脊髓GABA能信号的双位点调控产生持续镇痛。
- NTSR2是非阿片类镇痛的新靶点,支持其用于慢性疼痛治疗。
研究设计与样本
- 在雄性和雌性大鼠及小鼠的围术期与慢性疼痛模型中评估NT79的镇痛行为。
- 动物随机接受生理盐水对照或NT79多剂量。
- 采用CRISPR/Cas9介导的NTSR2敲低和GABA受体药理学抑制解析NTSR2依赖机制。
- 采用DRG钙成像、全细胞膜片钳电生理和脊髓神经递质检测评估机制。
主要发现
- 鞘内NT79在多种疼痛模型、种属和性别中产生稳健的剂量依赖性镇痛。
- NTSR2敲低可废除NT79的镇痛效应。
- NT79降低DRG神经元高电压激活钙电流,提示突触前抑制机制。
- NT79增强脊髓GABA释放并抑制CGRP释放。
- GABA受体药理学阻断或GABA能神经元中NTSR2敲低部分逆转NT79镇痛效应。
临床怎么用
- NTSR2激动代表一种非阿片类镇痛策略,可能同时调控外周和脊髓环路。
- 脊髓GABA能信号和外周钙通道抑制是NTSR2镇痛的关键环节,可作为机制监测或联合靶点。
局限性
- 研究为啮齿类动物模型,结果尚未在人体验证。
- GABA受体阻断仅部分逆转NT79镇痛,提示存在其他机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The potential to mitigate pain by targeting a single receptor while simultaneously modulating peripheral and spinal circuits, offers an exciting nonopioid therapeutic strategy. Neurotensin receptor type 2 (NTSR2) is a promising yet underexplored pathway for nonopioid analgesia. The authors investigated the antinociceptive effects of NTSR2 activation and its mechanisms in rodent models of perioperative and chronic pain. METHODS: Using NT79, a selective NTSR2 agonist, the authors assessed pain behaviors in male and female rats and mice. Animals were randomly assigned to receive saline (control) or NT79 at multiple doses. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated NTSR2 knockdown and pharmacologic inhibition of γ-aminobutyric acid (GABA) receptors were used to dissect NTSR2-dependent mechanisms. Dorsal root ganglion (DRG) calcium imaging, whole cell patch clamp electrophysiology, and spinal neurotransmitter assays evaluated the modulation of voltage-gated calcium channels and γ-aminobutyric acid-mediated (GABAergic) signaling. RESULTS: Intrathecal NT79 produced robust, dose-dependent antinociception across pain models, species, and sexes, an effect abolished by NTSR2 knockdown. NT79 reduced high-voltage-activated calcium currents in DRG neurons, indicating a presynaptic inhibitory mechanism. In the spinal cord, NT79 enhanced GABA release and suppressed calcitonin gene-related peptide (CGRP) release. Pharmacologic blockade of GABA receptors partially reversed NT79's antinociceptive effects, as did NTSR2 knockdown in GABAergic neurons, supporting a central GABAergic mechanism in addition to the effect on central DRG terminals. CONCLUSIONS: Taken together, these results demonstrate that NTSR2 activation produces sustained antinociception via dual-site modulation: inhibition of peripheral voltage-gated calcium channels and enhancement of spinal GABAergic signaling. These findings identify a novel, nonopioid mechanism of analgesia and support NTSR2 as a therapeutic target for chronic pain.
引用
- Martin LF, Gomez K, Park J, et al. Dual Roles of Voltage-gated Calcium Channels and γ-Aminobutyric Acid-mediated Signaling in Modulating Neurotensin Receptor Type 2-induced Antinociception. Anesthesiology. 2026. PMID: 42262386. doi:10.1097/ALN.0000000000006077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。